Upgrade to SI Premium - Free Trial

Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho

June 23, 2026 9:59 AM
Mizuho analyst Graig Suvannavejh lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $34.00 (from $44.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change